Literature DB >> 6662180

The binding of ibuprofen to plasma proteins.

L Aarons, D M Grennan, M Siddiqui.   

Abstract

The binding of ibuprofen to human serum albumin, normal plasma and plasma obtained from rheumatoid arthritic patients was studied using the method of ultracentrifugation. It was found that ibuprofen is more strongly bound to normal plasma than to human serum albumin although this result is probably explained by fatty acid contamination of the human serum albumin. The fraction of ibuprofen not bound to normal plasma rose significantly from a value of 0.0128 at an ibuprofen concentration of 2 mg X l-1 to 0.0155 at a concentration of 50 mg X l-1. Ibuprofen was less strongly bound to rheumatoid plasma than to normal plasma but this difference can be accounted for by the difference in albumin concentration between the two plasmas. It was found that salicylic acid can displace ibuprofen from protein binding sites, in vitro, and that this is the probable cause of the pharmacokinetic interaction between the two drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662180     DOI: 10.1007/bf00542526

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The aspirin-ibuprofen interaction in rheumatoid arthritis.

Authors:  D M Grennan; D G Ferry; M E Ashworth; R E Kenny; M Mackinnon
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

3.  Binding of nonsteroidal anti-inflammatory agents to proteins--I. Ibuprofen-serum albumin interaction.

Authors:  J B Whitlam; M J Crooks; K F Brown; P V Pedersen
Journal:  Biochem Pharmacol       Date:  1979-03-01       Impact factor: 5.858

4.  The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs.

Authors:  A Kober; I Sjöholm
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

Review 5.  Plasma protein binding and therapeutic drug monitoring.

Authors:  M Rowland
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

6.  Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  S Wanwimolruk; D J Birkett; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

7.  The metabolism of ibuprofen.

Authors:  R F Mills; S S Adams; E E Cliffe; W Dickinson; J S Nicholson
Journal:  Xenobiotica       Date:  1973-09       Impact factor: 1.908

8.  Protein binding of tolmetin.

Authors:  M L Selley; B W Madsen; J Thomas
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

  8 in total
  14 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication.

Authors:  V K Cheruvallath; C M Riley; S R Narayanan; S Lindenbaum; J H Perrin
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

3.  Interpreting physicochemical experimental data sets.

Authors:  Nicola Colclough; Mark C Wenlock
Journal:  J Comput Aided Mol Des       Date:  2015-06-09       Impact factor: 3.686

Review 4.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

5.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

7.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Renal handling and effects of S(+)-ibuprofen and R(-)-ibuprofen in the rat isolated perfused kidney.

Authors:  P G Cox; W M Moons; F G Russel; C A van Ginneken
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Conjugation to albumin-binding molecule tags as a strategy to improve both efficacy and pharmacokinetic properties of the complement inhibitor compstatin.

Authors:  Yijun Huang; Edimara S Reis; Patrick J Knerr; Wilfred A van der Donk; Daniel Ricklin; John D Lambris
Journal:  ChemMedChem       Date:  2014-07-23       Impact factor: 3.466

10.  Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

Authors:  L Aarons; R Salisbury; M Alam-Siddiqi; L Taylor; D M Grennan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.